Southern First Bancshares, Inc. (SFST) Is At $46.30 Formed Wedge; Genesis Healthcare, Inc. (GEN) Covered By 1 Bullish Analysts Last Week

Southern First Bancshares, Inc. (NASDAQ:SFST) Logo

Among 7 analysts covering Genesis Healthcare (NYSE:GEN), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. Genesis Healthcare had 19 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Genesis Healthcare, Inc. (NYSE:GEN) earned “Hold” rating by RBC Capital Markets on Monday, June 12. UBS downgraded the shares of GEN in report on Monday, February 8 to “Sell” rating. As per Monday, March 19, the company rating was maintained by Stephens. Cantor Fitzgerald maintained the shares of GEN in report on Thursday, August 10 with “Buy” rating. RBC Capital Markets maintained it with “Outperform” rating and $5 target in Tuesday, January 26 report. RBC Capital Markets downgraded it to “Sector Perform” rating and $3.50 target in Monday, November 21 report. On Monday, July 17 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Sector Perform” rating on Monday, August 10 by RBC Capital Markets. The firm has “Neutral” rating given on Tuesday, January 26 by Bank of America. UBS maintained Genesis Healthcare, Inc. (NYSE:GEN) rating on Monday, November 9. UBS has “Neutral” rating and $5.50 target. See Genesis Healthcare, Inc. (NYSE:GEN) latest ratings:

11/05/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $7.0000 Maintain
24/04/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $2.0000 Maintain
19/03/2018 Broker: Stephens Rating: Hold New Target: $2.0 Maintain

Southern First Bancshares, Inc. (SFST) formed wedge up with $48.62 target or 5.00% above today’s $46.30 share price. Southern First Bancshares, Inc. (SFST) has $341.77M valuation. The stock decreased 0.96% or $0.45 during the last trading session, reaching $46.3. About 21,291 shares traded or 59.27% up from the average. Southern First Bancshares, Inc. (NASDAQ:SFST) has risen 34.76% since June 14, 2017 and is uptrending. It has outperformed by 22.19% the S&P500.

Among 4 analysts covering Southern First Bancshares (NASDAQ:SFST), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Southern First Bancshares had 4 analyst reports since August 20, 2015 according to SRatingsIntel. Wood maintained the shares of SFST in report on Thursday, August 20 with “Outperform” rating. The company was downgraded on Tuesday, November 29 by Keefe Bruyette & Woods. Sandler O’Neill maintained the shares of SFST in report on Thursday, January 25 with “Buy” rating.

Since January 26, 2018, it had 0 insider purchases, and 12 selling transactions for $1.31 million activity. CUBBAGE LEIGHTON M also sold $64,425 worth of Southern First Bancshares, Inc. (NASDAQ:SFST) on Monday, March 26. $20,418 worth of Southern First Bancshares, Inc. (NASDAQ:SFST) shares were sold by Strickland F Justin. Dowling Michael D sold $141,125 worth of stock or 3,000 shares. Shares for $50,184 were sold by ELLEFSON ANNE S on Tuesday, May 1. 9,983 shares valued at $468,194 were sold by SEAVER R ARTHUR JR on Wednesday, May 9.

Investors sentiment decreased to 1.17 in 2018 Q1. Its down 0.48, from 1.65 in 2017Q4. It is negative, as 3 investors sold Southern First Bancshares, Inc. shares while 21 reduced holdings. 5 funds opened positions while 23 raised stakes. 4.95 million shares or 1.31% more from 4.88 million shares in 2017Q4 were reported. Elizabeth Park Capital Advsr Limited has invested 2.44% in Southern First Bancshares, Inc. (NASDAQ:SFST). Northwestern Mutual Wealth Mgmt invested in 266 shares or 0% of the stock. First Trust Advisors Limited Partnership owns 15,050 shares. Eam Lc invested in 0.11% or 15,277 shares. 4,658 were reported by Lpl Fincl Ltd Liability Corporation. Castine Mgmt Lc accumulated 2.83% or 195,910 shares. Blackrock holds 0% or 311,745 shares. Voya Investment Mgmt owns 4,967 shares or 0% of their US portfolio. The North Carolina-based Sheets Smith Wealth Management has invested 0.15% in Southern First Bancshares, Inc. (NASDAQ:SFST). 292,964 are held by Vanguard Grp Incorporated Inc. Globeflex Limited Partnership has 0.08% invested in Southern First Bancshares, Inc. (NASDAQ:SFST). Acadian Asset Limited Liability Corp has invested 0% of its portfolio in Southern First Bancshares, Inc. (NASDAQ:SFST). Jpmorgan Chase And, a New York-based fund reported 1,329 shares. Rhumbline Advisers holds 0% or 5,497 shares. California State Teachers Retirement Systems has 0% invested in Southern First Bancshares, Inc. (NASDAQ:SFST).

Analysts await Southern First Bancshares, Inc. (NASDAQ:SFST) to report earnings on July, 24. They expect $0.67 EPS, up 36.73% or $0.18 from last year’s $0.49 per share. SFST’s profit will be $4.95M for 17.28 P/E if the $0.67 EPS becomes a reality. After $0.67 actual EPS reported by Southern First Bancshares, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

The stock increased 5.26% or $0.12 during the last trading session, reaching $2.4. About 1.05M shares traded or 51.92% up from the average. Genesis Healthcare, Inc. (NYSE:GEN) has risen 5.21% since June 14, 2017 and is uptrending. It has underperformed by 7.36% the S&P500. Some Historical GEN News: ; 17/05/2018 – Genesis Global Trading Granted BitLicense in New York State; 28/04/2018 – NYC Parks & Rec: Month of Sundays at Genesis Community Garden Bronx; 23/04/2018 – Genesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., Ltd; 25/05/2018 – Genesis Essentia Concept Makes Concours Debut At Concorso d’Eleganza Villa d’Este; 17/05/2018 – Genesis Global Trading Granted BitLicense by New York Department of Financial Services; 06/03/2018 Genesis HealthCare Closes on Previously Announced Financing Commitments; 16/03/2018 – Genesis Healthcare 4Q Adjusted EBITDAR $143.6M; 18/03/2018 – Canon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke Solutions; 18/04/2018 – Origin Successfully Achieves Phase IIb GENESIS Trial Objectives Ahead of Schedule and Announces Early Termination of Study; 18/03/2018 – Canon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke Solutions

Southern First Bancshares, Inc. (NASDAQ:SFST) Institutional Positions Chart